Researchers have identified a potential new drug target for treating lung cancer.
In a new study by University of Kentucky Markey Cancer Center researchers have suggested that targeting a key enzyme and its associated metabolic programming may lead to novel drug development to treat the disease.
The study collected metabolic data directly from more than 120 human lung cancer patients. UK's Center for Environmental and Systems Biochemistry (CESB) researchers measured the in situ activity ...
Researchers have identified a potential new drug target for treating lung cancer.
In a new study by University of Kentucky Markey Cancer Center researchers have suggested that targeting a key enzyme and its associated metabolic programming may lead to novel drug development to treat the disease.
The study collected metabolic data directly from more than 120 human lung cancer patients. UK's Center for Environmental and Systems Biochemistry (CESB) researchers measured the in situ activity ...